Tag Archive for: Ethris

Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) has granted  US$5m to RNA formulation specialis Ethris to support studies that demonstrate spray-dried RNA vaccines remain stable at room temperature and are suitable for mucosal delivery. 

Cipla EU Ltd is going to make an equity investment of €15m in Ethris GmbH, a specialist for respiratory  delivery of therapeutic mRNAs.

CEPI fights the betacoronaviruses by funding Ethris GmbH and DIOSynVax Ltd and their joint effort to advance their work on an mRNA vaccine.